ACUTE GOUTY ARTHRITIS
Clinical trials for ACUTE GOUTY ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE GOUTY ARTHRITIS trials appear
Sign up with your email to follow new studies for ACUTE GOUTY ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug firsekibart tested to stop painful gout attacks
Disease control Not yet recruitingThis study will follow 264 adults with frequent gout flares to see how often attacks return within 24 weeks after starting firsekibart. Researchers will also track side effects and how quickly flares resolve. The goal is to understand if this medication helps control gout in ever…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New study tests best way to use firsekibart to stop gout attacks
Disease control Not yet recruitingThis study looks at whether taking Firsekibart regularly (every 4 weeks) is better than using it only when a gout flare starts. It involves 118 adults who had no flares during 24 weeks of initial treatment. The goal is to see which approach prevents more gout attacks over the nex…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Experimental pill aims to knock out gout pain within hours
Symptom relief Not yet recruitingThis study tests an experimental drug called HRS-2129 in adults experiencing a sudden, painful gout flare. The goal is to see if it can safely reduce joint pain within 24 hours compared to a placebo. Researchers are also looking at how well different doses work and how quickly pa…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC